Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Davis

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Virology|August 1, 1990
Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intronB B Mason, A R Davis, B M Bhat, et al.
Vaccine|May 1, 1994
Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret modelK H Hsu, M D Lubeck, B M Bhat, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog modelR J Natuk, P K Chanda, M D Lubeck, et al.
Molecular Pharmacology|April 1, 1993
Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptorP K Chanda, M C Minchin, A R Davis, et al.
Archives of Virology|January 1, 1991
Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vectorW W Ye, B B Mason, M Chengalvala, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirusM D Lubeck, A R Davis, M Chengalvala, et al.
International Reviews of Immunology|January 1, 1990
Helper independent recombinant adenovirus vectors: expression of HIV env or HBV surface antigenP K Chanda, R J Natuk, S K Dheer, et al.
Virology|April 1, 1990
High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinantsP K Chanda, R J Natuk, B B Mason, et al.
Vaccine|June 1, 1994
Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1N K Kalyan, S G Lee, J Wilhelm, et al.
The Journal of Infectious Diseases|October 1, 1992
Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzeeK H Hsu, M D Lubeck, A R Davis, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Virology|August 1, 1990
Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intronB B Mason, A R Davis, B M Bhat, et al.
Vaccine|May 1, 1994
Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret modelK H Hsu, M D Lubeck, B M Bhat, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog modelR J Natuk, P K Chanda, M D Lubeck, et al.
Molecular Pharmacology|April 1, 1993
Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptorP K Chanda, M C Minchin, A R Davis, et al.
Archives of Virology|January 1, 1991
Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vectorW W Ye, B B Mason, M Chengalvala, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirusM D Lubeck, A R Davis, M Chengalvala, et al.
International Reviews of Immunology|January 1, 1990
Helper independent recombinant adenovirus vectors: expression of HIV env or HBV surface antigenP K Chanda, R J Natuk, S K Dheer, et al.
Virology|April 1, 1990
High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinantsP K Chanda, R J Natuk, B B Mason, et al.
Vaccine|June 1, 1994
Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1N K Kalyan, S G Lee, J Wilhelm, et al.
The Journal of Infectious Diseases|October 1, 1992
Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzeeK H Hsu, M D Lubeck, A R Davis, et al.
Pageof 15